ASX:MYX

Mayne Pharma Group Limited · ASX · Healthcare · AUD · FY for 2026

Figures on this page computed 2026-11-08 13:00 UTC

Last close

n/aAUD

Market data

9.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed
- Computed from the filing for 2026
-8.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
6.4%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
3.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
0.11Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed

Safety is the furthest below its sector's middle: 0.45 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

67.0

2017-06-30 to 2026-06-30100 at the start67.0

Sales: 100.00 on 2017-06-30 to 67.01 on 2026-06-30, down 33%.

Profit

27.6

2017-06-30 to 2026-06-30100 at the start27.6

Profit: 100.00 on 2017-06-30 to 27.63 on 2026-06-30, down 72%.

Shares in issue

131

2017-06-30 to 2026-06-30100 at the start131

Shares in issue: 100.00 on 2017-06-30 to 130.82 on 2026-06-30, up 31%.

Sales is at 67, Profit is at 28, Shares in issue is at 131, against 100 in 2017.

Sales is at 67, Profit is at 28, Shares in issue is at 131, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales, where the first year is 10067
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Profit, where the first year is 10028
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Shares in issue, where the first year is 100131
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD